Opinion|Videos|August 1, 2024
Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources
Author(s)Panagis Galiatsatos, MD
Panagis Galiatsatos, MD, MHS, provides clinical insights on resources and factors that inform the treatment of patients with bronchiectasis.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- How do treatment goals and outcome measures for bronchiectasis differ from those of COPD, particularly regarding FEV and exacerbation rates?
- In the absence of U.S.-based treatment guidelines, what resources do you use to make clinical decisions for bronchiectasis management?
Advertisement
Related to this article
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Advertisement
Advertisement
Trending on AJMC
1
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
2
Using Complement Inhibitors in GA Comes With Pros and Cons
3
Pairing VYD2311 With mRNA COVID-19 Vaccines: Michael Mina, MD, PhD
4
New Mechanism of DME Treatment Highlights Clinical Trial Updates
5